LARSON MATTHEW PAUL 4
4 · Slide Insurance Holdings, Inc. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Slide Insurance (SLDE) CRO Matthew Larson Exercises Options, Sells 13,750 Shares
What Happened
Matthew Paul Larson, Chief Risk Officer of Slide Insurance Holdings (SLDE), exercised stock options to acquire 13,750 shares (8,998 shares at $0.79 and 4,752 shares at $1.38) for a total exercise cost of $13,666, then sold those 13,750 shares in an open-market transaction on June 10, 2026 for aggregate proceeds of $234,713 (weighted avg price $17.07).
Key Details
- Transaction date: June 10, 2026; Form 4 filed June 12, 2026 (within the 2-business-day filing window).
- Options exercised: 8,998 shares @ $0.79 ($7,108) and 4,752 shares @ $1.38 ($6,558).
- Shares sold: 13,750 shares @ weighted avg $17.07, total reported proceeds $234,713; sale prices ranged $17.00–$17.19.
- The sale was executed pursuant to a 10b5-1 trading plan adopted Dec 4, 2025.
- Reporting of derivative dispositions at $0 reflects the conversion/exercise of options into common shares.
- Options reported in the filing total 55,000; 27,500 are vested and exercisable, with the remaining 27,500 vesting ratably on July 14, 2026 and July 14, 2027. (The options exercised were fully vested and exercisable.)
Context
- This was an exercise-plus-sell transaction (the shares acquired from options were sold the same day). Such transactions are commonly used to realize value from vested options and do not, by themselves, indicate a change in the insider’s view of the company.
- The use of a 10b5-1 plan indicates the sales were pre-planned and executed under an established trading program.
Insider Transaction Report
Form 4
LARSON MATTHEW PAUL
Chief Risk Officer
Transactions
- Exercise/Conversion
Common Stock
2026-06-10$0.79/sh+8,998$7,108→ 8,998 total - Exercise/Conversion
Common Stock
2026-06-10$1.38/sh+4,752$6,558→ 13,750 total - Sale
Common Stock
[F1][F2]2026-06-10$17.07/sh−13,750$234,713→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F3]2026-06-10−8,998→ 0 totalExercise: $0.79Exp: 2032-02-24→ Common Stock (8,998 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F4]2026-06-10−4,752→ 50,248 totalExercise: $1.38Exp: 2032-02-24→ Common Stock (4,752 underlying)
Footnotes (4)
- [F1]Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025.
- [F2]Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $17.00 to $17.19 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F3]These stock options are fully vested and exercisable.
- [F4]Of the 55,000 stock options reported herein, 27,500 are vested and exercisable. The remaining 27,500 vest ratably on July 14, 2026 and July 14, 2027.
Signature
/s/ Anastasios Omiridis, Attorney-in-Fact for Matthew Larson|2026-06-12